Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

49

Revenue 2017

Janumet

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Janumet was produced by Merck & Co..

Merck pulls Keytruda filing in Europe, despite US approval

Merck pulls Keytruda filing in Europe, despite US approval

portfolio after its Januvia/Janumet diabetes franchise.

FDA won't add outcomes data to Januvia label

FDA won't add outcomes data to Januvia label The US regulator has sent the pharma company a complete response letter for DPP-4 inhibitor Januvia (sitagliptin) and combination product Janumet (sitagliptin plus metformin) - along with extended release formulations - saying

Merck drops once-weekly diabetes drug in US and EU

Merck drops once-weekly diabetes drug in US and EU Januvia and companion drug Janumet (sitagliptin plus metformin) brought in revenues of just over $6bn last year, in line with 2014, and the once-buoyant growth of the franchise has been

Dr Susanne Fiedler takes over as CEO of MSD Germany

Dr Susanne Fiedler takes over as CEO of MSD Germany Since then Dr Fielder has served in the US, where MSD operates at Merck &Co, as global brand leader for the diabetes treatments Januvia and Janumet, before taking up a

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales

BMS pulls ahead of Merck in quarterly PD-1 inhibitor sales Merck meanwhile posted revenues of $10.07bn, a 2% increase, with its Januvia (sitagliptin) and Janumet (sitagliptin and metformin) diabetes franchise leading the charge with sales 9% to $1.01bn and

1 2 3 4 5 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics